Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

Autoria(s): Huynh, H.; Chow, P.K.H.; Palanisamy, N.; Salto-Tellez, Manuel; Goh, B.C.; Lee, C.K.; Somani, A.; Lee, H.S.; Kalpana, R.; Yu, K.; Tan, P.H.; Wu, J.; Soong, R.; Lee, M.H.; Hor, H.; Soo, K.C.; Toh, H.C.; Tan, P.
Data(s)

01/07/2008
Resumo

Background/Aims: Hepatocellular carcinoma is a leading cause of global cancer mortality, with standard chemotherapy being minimally effective in prolonging survival. We investigated if combined targeting of vascular endothelial growth factor protein and expression might affect hepatocellular carcinoma growth and angiogenesis.
Identificador

http://pure.qub.ac.uk/portal/en/publications/bevacizumab-and-rapamycin-induce-growth-suppression-in-mouse-models-of-hepatocellular-carcinoma(cacd45cb-e878-48dc-aa03-cb8f1d1791c3).html

http://dx.doi.org/10.1016/j.jhep.2008.02.022
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Huynh , H , Chow , P K H , Palanisamy , N , Salto-Tellez , M , Goh , B C , Lee , C K , Somani , A , Lee , H S , Kalpana , R , Yu , K , Tan , P H , Wu , J , Soong , R , Lee , M H , Hor , H , Soo , K C , Toh , H C & Tan , P 2008 , ' Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma ' Journal of Hepatology , vol 49 , no. 1 , pp. 52-60 . DOI: 10.1016/j.jhep.2008.02.022
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2715 #Gastroenterology
Tipo

article
Acesso ao item digital